Kinch MS. Fiduciary Responsibility. Drug Discovery Today. 2023 Oct 5:103794. doi: 10.1016/j.drudis.2023.103794.

Outside government, few industries are as important to everyday life, and yet negatively perceived, as pharmaceuticals. The Federal government and pharmaceuticals share spots at the very bottom, with 58% voicing negative sentiments according to Gallup. Such opinions are all the more remarkable given the vaccines and therapeutics, which saved countless lives and allowed the world to emerge from COVID-19. Public distrust reflects opacity and pricing decisions that consistently outpace inflation. I serve neither as an apologist for, nor an irrational critic of, the actions of the pharmaceutical industry. Nonetheless, I remain amazed at how often key decisions are dismissed with a figurative wave of the hand that leadership is simply upholding its “fiduciary responsibility.”

Volunteer

Navigation

Latest Research

Antibiotic Development: Lessons from the Past and Future Opportunities

2023 in review: FDA approvals of new medicines

Unintended Consequences: The Risks of Vacating COVID19 Vaccine Patents.